Similar articles

• Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.

  Lin Y, Sobis H, Vandeputte M, Waer M. Lin Y, et al. Transplant Proc. 1994 Dec;26(6):3202. Transplant Proc. 1994. PMID: 7998115 No abstract available.
• Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.

  Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW. Xiao F, et al. Transplant Proc. 1994 Jun;26(3):1263-5. Transplant Proc. 1994. PMID: 8029902 No abstract available.
• Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.

  Foster PF, Kociss K, Shen J, Sankary HN, Xiao F, Williams JW. Foster PF, et al. Transplant Proc. 1996 Oct;28(5):2527-8. Transplant Proc. 1996. PMID: 8907935 No abstract available.
• Treatment strategies of hamster-to-rat cardiac xenotransplantation.

  Steinbrüchel DA, Nielsen B, Kemp E. Steinbrüchel DA, et al. Transplant Proc. 1994 Apr;26(2):1039-41. Transplant Proc. 1994. PMID: 8171460 Review. No abstract available.
• Pathogenesis and mechanisms of graft rejection in concordant xenotransplantation with special reference to hamster-to-rat cardiac transplantation.

  Steinbrüchel DA. Steinbrüchel DA. APMIS Suppl. 1996;58:5-45. doi: 10.1111/j.1600-0463.1996.tb05559.x. APMIS Suppl. 1996. PMID: 8608038 Review. No abstract available.